Sidoti Downgrades Zoll Medical (ZOLL) to Neutral, Maintains $74 Price Target
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq hit record highs as Treasury yields stall, oil slips
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
Tweet
Share
E-mailGet Alerts ZOLL Hot Sheet
Price: $93.00 --0%
Rating Summary:
1 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 26 | Down: 17 | New: 36
Rating Summary:
1 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 26 | Down: 17 | New: 36
Join SI Premium – FREE
Sidoti downgraded shares of Zoll Medical (NASDAQ: ZOLL) to a Neutral rating from its previous rating of Buy. The firm reiterated its price target of $74.00.
For more ratings news on Zoll Medical click here and for the rating history of Zoll Medical click here.
Shares of Zoll Medical closed at $68.38 yesterday.
For more ratings news on Zoll Medical click here and for the rating history of Zoll Medical click here.
Shares of Zoll Medical closed at $68.38 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BTIG Downgrades Personalis (PSNL) to Neutral
- Goldman Sachs Downgrades Gentex (GNTX) to Sell
- JPMorgan Downgrades Schneider Electric SE (SU:FP) (SBGSY) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
Sidoti & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
